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ABSTRACT 
 
Introduction and literature review: 
Malaria is a distressing health problem that posses a socio-
economic burden of considerable magnitude for communities in 
developing countries. It causes some immunological and hematological 
changes particularly inflammatory biomarkers and hemoglobin.  
Research is extensively required in this area to promote health services 
and to target radical solution to the problem.  
The objective of the study is to investigate some inflammatory and 
other biomarkers during malaria infections in some of Sudanese children 
in Sinar State and how these biomarkers may relate to factors such as age 
and hemoglobin which in children may be important in disease 
progression and control. 
Materials and Methods: 
Thirty-two samples of blood were collected from 16 malaria 
patients from Sinar hospital and 16 apparently healthy individuals from 
the same area as control group from which serum was separated. 
The investigations were carried out to estimate serum C-reactive 
protein (CRP), tumor necrosis factor alpha (TNF α) and serum 
magnesium in the two groups. 
High sensitive and highly specific techniques were used for 
biomarker determinations. 
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Results: 
Results showed that children of different age groups with Malaria 
have significantly higher levels of C-reactive protein.  
Compared with the control, serum magnesium levels were below 
normal ranges in the malaria patients, while serum tumor necrosis factor 
was significantly high among malaria patients. The hemoglobin level was 
low in most of infected children, there was no correlation between serum 
magnesium levels and hemoglobin.  
Discussion and Conclusion: 
 It is concluded that malaria is one of the causes of biomarker 
changes. C-reactive protein concentrations were increased in malaria 
patients and of high incidence among children. TNF level was increased 
in patients .Serum magnesium level was decreased in malaria patients in 
this study, The increase of CRP and TNF concentration may be attributed 
to the severe inflammation in children as they known as inflammatory 
bio markers . but the hemoglobin which was low in the infected children 
was due to anemia and bad nutrition status. There was negative  
correlation between serum magnesium and hemoglobin levels.   
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INTRODUCTION 
 Malaria is a serious infectious disease spread by mosquitoes and 
endemic in many developing countries. It is common in tropical climates 
and is characterized by chills, fevers, and an enlarged spleen. Malaria is 
caused by protozoan parasites of the genus Plasmodium. In humans 
malaria is caused by P. falciparum, P. malarae, P. ovale, and P. vivax. 
However, P. falciparum is the most important cause of the disease and 
responsible for about 80% of malaria infections (Mendis et al., 2000). 
 Malaria causes about 350–500 million infections in humans and 
approximately one to three million deaths annually (Breman, 2001). The 
vast majority of cases occur in children under the age of 5 years 
(Greenwood et al., 2005). Pregnant women are especially vulnerable. 
Despite efforts since 1992 to reduce transmission and increase treatment, 
there has been little change in areas at risk of this disease (Hay. et al., 
2004). Methods used to prevent the spread of the disease, or to protect 
individuals in areas where malaria is endemic, include drugs, mosquito 
eradication, and the prevention of mosquito bites. Currently there is no 
vaccine that will prevent malaria, but this is an active field of research. It 
is hoped that the sequencing of the P. falciparum genome will provide 
targets for new drugs or vaccines (Gardner et al., 2002). 
 Over the past few decades, a literature has emerged that argues 
for most of the pathology seen in all of these infectious diseases being 
explained by activation of the inflammatory system, with the balance 
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between the pro- and anti-inflammatory cytokines being tipped towards 
the onset of systemic inflammation. 
 There is now remarkably widespread acceptance that cytokines 
such as TNF and interleukin-1 constitute the essential mechanism of 
systemic disease caused by infectious agents. Indeed, one would be 
pressed to find an alternative explanation for the anorexia, tiredness, 
aching joints and muscles, fever and sleepiness that patients experience 
in any systemic infection, including both vivax and falciparum malaria 
(Ubalee  et al., 2001 ). Tumor necrosis factor alpha (TNF-α) is thought to 
play a role in the development of immunity and pathology in malaria 
infections in experimental models and in humans (Clark et al., 1992). In 
fact, the genetic susceptibility to severe forms of falciparum malaria is 
differentially associated with TNF-α promoter gene polymorphisms 
(Ubalee et al., 2001). As such TNF can be considered as a biomarker for 
malaria. 
 A biomarker is a characteristic that can be objectively measured 
and evaluated as an indicator of normal biological or pathogenic 
processes as well as pharmacological responses to a therapeutic 
intervention. Interest in biomarkers application for diagnostics and drug 
discovery as well as drug development has increased remarkably since 
the beginning of the 21st century. Biomarkers are useful not only for 
diagnosis of some of diseases but also for understanding the pathogenic 
mechanisms involved in disease (Clark et al., 1992).. 
 The information generated by testing for biomarkers can be used 
for three purposes: 
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1.  The assessment of needs and the planning of interventions to 
improve health. 
2.  The monitoring of changes in health and the evaluation of 
interventions. 
3.  Lobbying for changes in policies to address population health 
needs. 
 Currently, no information is available about the biochemical or 
molecular signatures of severe and complicated malaria or mild and 
asymptomatic malaria. The detection of biomarkers of severe malaria, 
along with traditional microscopy, could result in effective management 
of malaria particularly in more vulnerable groups such as children. 
 Other biomarkers of inflammatory response, if malaria is 
considered as one; may include inflammatory interleukins such as IL-1, 
IL-6, IL-8 and IL-18 and acute phase proteins such as C-reactive protein. 
A distinct molecular variant of disease-specific CRP was affinity purified 
from sera of malaria patients (CRPMal). This CRP showed strong binding 
with malaria erythrocytes (RBCMal) (Joy et al., 2003). These studies 
provide direct evidence for an important functional interaction of this 
acute-phase protein by triggering the CRP-complement pathway after it 
binds with RBCMal. Hemolysis as triggered by this pathway may be one 
of the causative factors of anemia, a common clinical manifestation of 
malaria to which over half of malaria-related deaths are attributed 
(Murphy et al., 2006). 
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 Since red blood cells contain high amounts of magnesium, 
hemolysis might result in increased serum magnesium. This offers a 
potential application of this element as a biomarker of acute falciparum 
malaria infection in adults (Rudin et al., 1997 ). 
Objectives: 
General objective: 
• To study the level of some inflammatory and other biomarkers during 
malarial infections. 
Specific objective: 
• To examine the serum levels of c-reactive proteins, tumor necrosis 
factor alpha in malarial infection. 
• To measure serum magnesium and hemoglobin level during malarial 
infections. 
• To investigate the correlation of magnesium with hemoglobin levels. 
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CHAPTER ONE 
LITERATURE REVIEW 
1.1 Malaria infection: 
 Malaria has infected humans for over 50,000 years, and may 
have been a human pathogen for the entire history of our species (Joy et 
al., 2003). The term malaria originates from Medieval Italian: mala aria - 
"bad air"; and the disease was formerly called ague or marsh fever due to 
its association with swamps. 
 Although the blood stage and mosquito stages of the malaria life 
cycle were established in the 19th and early 20th centuries, it was not 
until the 1980s that the latent liver form of the parasite was observed 
(Krotoski et al., 1982). The discovery of this latent form of the parasite 
finally explained why people could appear to be cured of malaria but still 
relapse after the parasite had disappeared from their blood streams. 
 Infection with Plasmodium falciparum can also lead to severe 
malaria, a heterogeneous syndrome involving respiratory and 
neurological disturbances with significant mortality rate (Marsh. et al., 
1996). 
1.1.1 Malaria epidimiolgy: 
 Indeed, if the prevalence of malaria stays on its present upwards 
course, the death rate could double in the next twenty years (Breman, 
2001). Precise statistics are unknown because many cases occur in rural 
areas where people do not have access to hospitals or the means to afford 
health care. Consequently, the majority of cases are undocumented 
(Breman, 2001). 
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 The geographic distribution of malaria within large regions is 
complex, malarial and malaria-free areas are often found close to each 
other (Hay et al., 2004 ). In drier areas, outbreaks of malaria can be 
predicted with reasonable accuracy by mapping rainfall (Grover-Kopec  
et al., 1998). Malaria is presently endemic in a broad band around the 
equator, in areas of the Americas, many parts of Asia, and much of 
Africa as indicated in figure (1). 
 However, it is in sub-Saharan Africa where 85– 90% of malaria 
fatalities occur (Scott and Layne, 2000). Malaria is more common in 
rural areas than in cities (Hay et al., 2004 ).  For example, the cities of 
Vietnam, Laos and Cambodia are essentially malaria-free, but the disease 
is present in many rural regions in South East Asia (Trung et al., 2004). 
By contrast, in Africa malaria is present in both rural and urban areas, 
though the risk is lower in the larger cities due to higher levels of 
education and awareness of the problem and also because of the 
provision of better health services (Joy et al., 2003 ). 
1.1.2 Socio-economic effects of malaria: 
 Malaria is not just a disease commonly associated with poverty, 
but is also a cause of poverty and a major hindrance to economic 
development. The disease has been associated with major negative 
economic effects on regions where it is widespread. In its entirety, the 
economic impact of malaria has been estimated to cost Africa 12 billion 
US$ every year (Breman, 2001). The economic impact includes costs of 
of health care, working days lost due to sickness, days lost in education, 
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decreased productivity due to brain damage from cerebral malaria, and 
loss of investment and tourism. (Greenwood and Mutabingwa, 2002).  
 
 
 
Fig. (1): Areas of the world where malaria is endemic (coloured blue) 
Source: (Hay et al., 2004  ). 
 
 In some countries with a heavy malaria burden, the disease may account 
for as much as 40% of public health expenditure, 30-50% of inpatient 
admissions, and up to 50% of outpatient visits that it acounts as a real 
devastation for the economy and prosperity of developing countries (Joy 
et al., 2003 ). 
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1.1.3 Symptoms of malaria: 
 Symptoms of malaria vary  a great deal and may include fever, 
shivering, joint pain, vomiting, anemia caused by hemolysis, 
hemoglobinuria, and convulsions. There may be the feeling of tingling in 
the skin, particularly with malaria caused by P. falciparum. The classical 
symptom of malaria is cyclical occurrence of sudden coldness followed 
by rigor and then fever and sweating lasting four to six hours, occurring 
every two days in P. falciparum, P. vivax, P. ovale infections, and every 
three days in P. malariae (Marsh et al., 1996).For reasons that are poorly 
understood, but which may be related to high intracranial pressure, 
children with malaria frequently exhibit abnormal posturing, a sign that 
indicates severe brain damage (Idro et al., 2007). 
1.1.4 Consequences of malaria: 
 Malaria has been found to cause cognitive impairments, 
especially in children (Boivin, 2002). The widespread anemia that 
malaria precipitates during a period of rapid brain development may 
result in brain damage. This neurologic damage may also result from 
cerebral malaria to which children are more vulnerable (Boivin, 2002). 
 Malaria which almost exclusively caused by P. falciparum is a  
severe infection and usually arises 6-14 days after infection (Kain et al., 
1998 ). Consequencies of severe malaria include coma and death if 
untreated particularly in vulnerable individuals. Splenomegaly, severe 
headache, cerebral ischemia, hepatomegaly, hypoglycemia, and 
hemoglobinuria with renal failure may occur. Renal failure may cause 
blackwater fever, where hemoglobin from lysed red blood cells leaks into 
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the urine. Severe malaria can progress extremely rapidly and cause death 
within hours or days (Kain et al., 1998 ). In the most severe cases of the 
disease fatality rates can exceed 20%, even with intensive care and 
treatment (Kain et al., 1998). In endemic areas, treatment is often less 
satisfactory and the overall fatality rate for all cases of malaria can be as 
high as one in ten (Mockenhaupt et al., 2004). Over the longer term, 
developmental impairments have been documented in children who have 
suffered episodes of severe malaria (Carter et al., 2005). Chronic malaria 
is that seen in both P. vivax and P. ovale, but not in P. falciparum. Here, 
the disease can relapse months or years after exposure, due to the 
presence of latent parasites in the liver. The longest incubation period 
reported for a P. vivax infection is 30 years (Carter et al., 2005 ). 
1.1.5 Mosquito vectors and the Plasmodium life cycle: 
 The parasite's primary (definitive) hosts and transmission vectors 
are female mosquitoes of the Anopheles genus. (Two females of 
anopheles mosquito full of blood shown in Fig .3 ). Young mosquitoes 
first ingest the malaria parasite by feeding on an infected human carrier 
and the infected Anopheles mosquitoes carry Plasmodium sporozoites in 
their salivary glands. Once ingested, the parasite gametocytes taken up in 
the blood will further differentiate into male or female gametes and then 
fuse in the mosquito gut. This produces an ookinete that penetrates the 
gut lining and produces an oocyst in the gut wall. When the oocyst 
ruptures, it releases sporozoites that migrate through the mosquito's body 
to the salivary glands, ( the Plasmodium life cycleis shown in Fig-2), 
where they are then ready to infect a new human host. This type of 
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transmission is occasionally referred to as anterior station transfer (Kain 
et al., 1998  ). 
 Only female mosquitoes feed on blood, thus males do not 
transmit the disease. The females of the Anopheles genus prefer to feed at 
night. They usually start searching for a meal at dusk, and will continue 
throughout the night. Malaria parasites can also be transmitted by blood 
transfusions, although this is rare. A longitudinal study was conducted 
between October 1989 and February 1990 in a malaria holoendemic area 
of Gabon to determine the plasma concentration of various cytokines in 
individuals continuously exposed to infection with malaria parasites. No 
cases of severe malaria were seen and fever was the main presenting 
symptom of clinical malaria. Parasite rates were highest in children 6-9 
years old but clinical malaria was seen essentially in children below 6 
years of age   (Carter et al., 2005 ). 
1.1.6 The Malaria parasites: 
 Malaria is caused by protozoan parasites of the genus 
Plasmodium (phylum Apicomplexa). Parasitic Plasmodium species also 
infect birds, reptiles, monkeys, chimpanzees and rodent (Escalante and 
Ayala, 1994). There have been documented human infections with 
several simian species of malaria (Mens et al., 2006 ). 
               One aspect of severe malaria pathogenesis is an excessive or 
dysregulated inflammatory response to infection. With the 
characterization of Toll-like receptors (TLRs), which initiate 
inflammation upon detection of microbial products, involvement of TLRs 
in the host response to malaria has undergone intense investigation. 
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While TLRs appear to mediate inflammation in malaria infection and 
may contribute to development of severe malaria, it is unlikely that they 
operate in isolation from other components of innate immunity (Beare 
2006). 
        1.1.7 Diagnosis 
The most economic, preferred, and reliable diagnosis of malaria is 
microscopic examination of blood films because each of the four major 
parasite  species  has  distinguishing  characteristics.  Two  sorts of blood 
. 
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Fig. (2). Plasmodium life cycle (Source: Beare, 2006). 
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Figure (3): Two females of  anopheles mosquito full of blood 
  (Beare, 2006 ). 
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films are traditionally used. Thin films allow species identification 
because the parasite's appearance is best preserved in this preparation. 
Thick films allow the laboratory technologist to screen a larger volume of 
blood and are about eleven times more sensitive than the thin film. Thus  
picking up low levels of infection is easier on the thick film, but the 
appearance of the parasite is much more distorted and therefore 
distinguishing between the different species can be much more difficult. 
It is imperative to utilize both smears while attempting to make a 
definitive diagnosis (Mens et al., 2006). 
 Molecular methods such as rapid real-time assays based on the 
polymerase chain reaction are available in some clinical laboratories 
(Mens et al., 2006). They are being developed with the hope to deploy 
them in endemic areas. 
 Severe malaria is commonly misdiagnosed in Africa. In malaria-
endemic areas, parasitemia does not ensure a diagnosis of severe malaria 
because parasitemia can be incidental to other concurrent disease. Recent 
investigations suggest that malarial retinopathy is better than any other 
clinical or laboratory feature in distinguishing malarial from non-malarial 
coma (Beare, 2006). 
1.1.8 Malaria prognosis:  
 The parasite is relatively protected from attack by the body's 
immune system because for most of its human life cycle it resides within 
the liver and blood cells and is relatively invisible to immune 
surveillance. However, circulating infected blood cells are destroyed in 
the spleen as a part of  innate immune response to malaria  . To avoid this 
fate, the P. falciparum parasite displays adhesive proteins on the surface 
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of the infected blood cells, causing the blood cells to stick to the walls of 
small blood vessels, thereby sequestering the parasite from passage 
through the general circulation and the spleen (Chen et al., 2000). This 
"stickiness" is the main factor giving rise to hemorrhagic complications 
of malaria. High endothelial venules (the smallest branches of the 
circulatory system) can be blocked by the attachment of masses of these 
infected red blood cells (Mens et al., 2006). 
1.1.9 Malaria and anemia: 
 Anemia commonly occurs in chronic infection, inflammation, 
and malignancy. This type of anemia is characterized by decreased 
plasma iron and iron-binding capacity, normal or elevated iron stores, 
modest decrease of red cell survival, and relative failure of bone marrow 
to increase red cell production and normal hemglobin level. It was first 
described with infection, because of its association with other types of 
chronic diseases such as chronic inflammation and cancer, it is called 
anemia of chronic diseases (ACD). An understanding of the role of 
inflammatory cytokines in the most of the diseases underlying ACD has 
suggested that such Inflammatory cytokines are important factors in the 
pathophysiology of ACD . TNF and IL-1 have effects on iron 
metabolism and red cell survival   in vivo, inflammatory cytokines have 
also been implicated in the inappropriately low erythropoietin (EPO) 
levels in ACD patients (Galasko D. 2001 ). 
                     Nutrition plays a major role in maintaining health, and 
malnutrition appears to generate vulnerability to a wide variety of 
diseases and general ill health. Opinions are mixed regarding how under 
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nutrition, whether it is characterized in terms of growth faltering or 
micronutrient malnutrition, affects susceptibility to malarial illness and 
mortality (Chen et al., 2000). 
 
1.1.10 Treatment: 
Treatment of malaria involves supportive measures as well as 
specific antimalarial drugs. When properly treated, someone with 
malaria can expect a complete cure (Boivin, 2002 ). 
1.1.10.1 Antimalarial drugs: 
Most drugs used in the treatment of malaria are active against the 
parasitic form in the blood (the form that causes the disease) and include: 
• chloroquine 
• sulfadoxine-pyrimethamine (Fansidar®) 
• mefloquine (Lariam®) 
• atovaquone-proguanil (Malarone®) 
• quinine 
• Doxycycline 
• artemisin derivatives 
In addition, primaquine is active against the dormant parasitic liver 
forms (hypnozoites) and prevents relapses.  
 Chloroquine is very cheap and until recently, was very effective, 
which made it the antimalarial drug of choice for many years in most 
parts of the world. However, resistance of Plasmodium falciparum to 
chloroquine has spread recently from Asia to Africa, making the drug 
ineffective against the most dangerous Plasmodium strain in many 
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affected regions of the world. In those areas where chloroquine is still 
effective it remains the first choice. Unfortunately, chloroquine-
resistance is associated with reduced sensitivity to other drugs such as 
quinine and amodiaquine (Killeen et al., 2002). 
Artemisinin is a new antimalarial drug of Chinese origin, derived 
from the herb Artemisia annua L., (sweet wormwood) belonging to the 
family of Asteraccae.  
 
 
  
Artmethinin 
 
 
Figure (4): Artmethinin chemical structure ( Mens et al., 2006). 
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1.1.10.2 Vaccination: 
  Asafe and effective vaccine would have been the easiest way to 
control malaria . however after decates of search avaccine is still ellusive. 
The first promising studies demonstrating the potential for a malaria 
vaccine were performed in 1967 by immunizing mice with live, 
radiation-attenuated sporozoites, providing protection to about 60% of 
the mice upon subsequent injection with normal, viable sporozoites  
(Matuschewski, 2006). Since the 1970s, there has been a considerable 
effort to develop similar vaccination strategies for humans. 
                The complex life cycle of the parasite involving human and 
vector mosquitoes as well as its allelic diversity and antigenic variations 
makes the development and implementation of effective malaria control 
intervention problematic. The immune response that correlates with 
protection in these lifelong residents of endemic areas has not been 
identified, so development of a vaccine that mimics this immunity will be 
difficult  (Galasko, 2001 ). 
               It is now becoming evident that multi-intervention approach 
may be the most appropriate way of combating malaria in view of the 
increasing resistance of the parasite to antimalarial drugs as well as 
vector mosquitoes to insecticides. Recent developments, including better 
methods for antigen production, improved adjuvants and novel delivery 
systems, provide optimism that sustained and appropriate long-lived 
immunity can be achieved (Matuschewski, 2006). 
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 Presently, there is a huge variety of vaccine candidates. Pre-
erythrocytic vaccines are vaccines that target the parasite before it 
reaches the blood. Other vaccine candidates include: those that seek to 
induce immunity to the blood stages of the infection; those that seek to 
avoid more severe pathologies of malaria by preventing adherence of the 
parasite to blood venules and placenta; and transmission-blocking 
vaccines that would stop the development of the parasite in the mosquito 
right after the mosquito has taken a bloodmeal from an infected person. It 
is hoped that the sequencing of the P. falciparum genome will provide 
targets for new drugs or vaccines.(Killeen, et al. 2002). 
1.1.10.3 Prevention and disease control: 
Mosquito nets help to keep mosquitoes away from people, and thus 
greatly reduce the infection and transmission of malaria. The nets are not 
a perfect barrier, so they are often treated with an insecticide designed to 
kill the mosquito before it has time to search for a way past the net. 
Insecticide-treated nets (ITN) are estimated to be twice as effective as 
untreated nets (Hull and Kevin, 2006) and offer greater than 70% 
protection compared with no net (Bachou, et al., 2006), Since the 
Anopheles mosquitoes feed at night, the preferred method is to hang a 
large "bed net" above the center of a bed such that it drapes down and 
covers the bed completely. 
Prevention is an important component of Malaria control in 
endemic countries is achieved through: 
• Preventing infection, by avoiding bites by parasite-carrying 
mosquitoes. 
• Preventing disease. 
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• Vector control 
• Personal protection measures such as insecticide-treated bed nets 
• Mosquito bite detergents, creams and sprays . 
• Preventive treatment with antimalarial drugs of vulnerable groups 
such as pregnant women, who receive intermittent preventive 
treatment. 
1.2 Biomarkers: 
1.2.1 Definition of biomarkers: 
 Biological markers (biomarkers) have been defined by Hulka and 
colleagues (Hulka,1990) as “cellular, biochemical or molecular 
alterations that are measurable in biological media such as human tissues, 
cells, or fluids. More recently, the definition has been broadened to 
include biological characteristics that can be objectively measured and 
evaluated as an indicator of normal biological processes, pathogenic 
processes, or pharmacological responses to a therapeutic intervention 
(Naylor, 2003). 
 Biomarkers of all types have been used by generations of 
epidemiologists, physicians, and scientists to study human disease. The 
application of biomarkers in the diagnosis and management of 
cardiovascular disease, infections, immunological and genetic disorders, 
and cancer are well known (Hulka, 1990). Their use in research has 
served more than a purpose (Gordis, 1996 ). Neuroscientists have relied 
on biomarkers such as β-amyloid protein in Alzheimer disease to assist in 
the diagnosis and treatment of nervous system disorders and to 
investigate their cause (Verbeek, et al., 2003).  
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 The rapid growth of molecular biology and laboratory 
technology has expanded to the point at which the application of 
technically advanced biomarkers will soon become even more feasible 
(Verbeek et al., 2003). 
1.2.2 Types of biomarkers: 
 Biomarkers have been classified by Perera and Weinstein (2000) 
on the basis of the sequence of events from exposure to disease 
manifestation. Schulte (1993) has outlined the capabilities of biomarkers 
as having the potential to identify the earliest events in the natural 
history, reducing the degree of misclassification of both disease and 
exposure. This opens the potential for depiction of mechanisms related to 
the disease pathogenesis. 
There are two major types of biomarkers: 
1. Biomarkers of exposure, which are used in risk prediction. 
2. Biomarkers of disease, which are used in screening and diagnosis 
and monitoring of disease progression. 
 Biomarkers used in risk prediction, in screening, and in 
diagnostic tests are well established, and they offer distinct and obvious 
advantages. Molecular biomarkers have the additional potential to 
identify individuals susceptibility to disease (Galasko, 2001). Molecular 
genetics have already had an impact on neurological practice, leading to 
improved diagnosis. Classification of populations in terms of the degree 
of susceptibility on the basis of such biomarkers produces greater 
accuracy than relying on historical definitions of susceptibility (Gordis, 
1996). For example, a biomarker will allow the stratification of a 
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population on the basis of a specific “genotype” associated with a disease 
rather than relying on a report of the “family history” of the disease. The 
ability to quantify “susceptibility” in this way can be an extremely 
important method for estimating disease risk among various populations. 
1.2.3 The validity of biomarkers: 
 The evaluation of the validity of a biomarker is complex. Schulte 
and Perera (1993) suggested three aspects of measurement validity: 1) 
content validity, which shows the degree to which a biomarker reflects 
the biological phenomenon studied, 2) construct validity, which pertains 
to other relevant characteristics of the disease or trait, for example other 
biomarkers or disease manifestations, and 3) criterion validity, which 
shows the extent to which the biomarker correlates with the specific 
disease and is usually measured by sensitivity, specificity, and predictive 
power (Gordis, 1996). 
 
1.2.4 Biomarkers in screening, diagnosis and prognosis: 
 Biomarkers depicting prodromal signs enable earlier diagnosis or 
allow for the outcome of interest to be determined at a more primitive 
stage of disease. Blood, urine, and cerebrospinal fluid provide the 
necessary biological information for the diagnosis. In these conditions, 
biomarkers are used as an indicator of a biological factor that represents 
either a sub- clinical manifestation or stage of the disorder. 
 Biomarkers used for screening or diagnosis also often represent 
surrogate manifestations of the disease. The potential uses of this class of 
biomarkers include: 1) identification of individuals destined to become 
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affected or who are in the “preclinical” stages of the illness, 2) reduction 
in disease heterogeneity in clinical trials or epidemiologic studies, 3) 
reflection of the natural history of disease encompassing the phases of 
induction, latency and detection, and 4) target for a clinical trial. 
1.2.5 Specific examples of biomarkers: 
 Biomarkers are too many , but to name a few will point to some 
inflammatory ones such as interleukins (IL-1, IL-6, IL-8 and IL-18), 
tumor necrosis factor , acute phase proteins such as C-reactive protein 
and magnesium . 
 
1.2.5.1 C-reactive protein (CRP): 
C- reactive protein is a best  characterized of the currently 
available inflammatory biomarkers and has emerged as a potential 
marker for cardiovascular risk (Ridker et al., 2002)  
C-reactive protein (CRP) is an ancient highly conserved molecule, 
secreted by the liver in response to trauma, inflammation, and infection 
and decreases just as rapidly with the resolution of the condition, it is  
composed of five subunits  , the measurement of CRP is widely used to 
monitor various inflammatory states that it released in the circulation 
plays a major role in human innate response  (DuClos, 2000). CRP binds 
to damage tissue, to nuclear antigens and to certain pathogenic organisms 
in a calcium-dependent manner, it activates complement, binds to Fc 
receptors and acts as an opsonin for various pathogens. Interaction of 
CRP with Fc receptors lead to the generation of pro-inflammatory 
cytokines that enhance the inflammatory response. (DuClos, 2000). 
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Normally there is no CRP in blood serum., "a high or increasing 
amount of CRP in your blood suggests that you have an acute infection 
or inflammation. Although a result above 1mg/dl is usually considered 
high for CRP, most infections and inflammations result in CRP levels 
above 10 mg/dl. 
Although the presence of C-reactive protein was found not to be 
specific, its disappearance from blood serum is correlated with treatment, 
so effect of some new drugs can now be studied in certain diseases, 
including malaria, with the C-reactive protein test (Naylor, 2003). 
 Although generally considered to be an acute-phase reactant, 
CRP is also produced in smooth muscle cells within human coronary 
arteries and is expressed preferentially in diseased vessels (Jabs et al., 
2003). CRP may directly affect expression of adhesion molecules, impact 
fibrinolysis, and alter endothelial dysfunction (Szmitko et al., 2003). 
Very recently, transgenic mice expressing human CRP have been shown 
to have an increased thrombotic risk and perhaps increased atherogenesis 
(Danenberg et al., 2003). 
 CRP is the most widely used of the acute phase inflammatory 
proteins because of its early rise and rapid kinetics (Imrie et al., 2007). 
Its half-life is 5 to 6 hours. CRP is concentrated in tissues involved in the 
inflammation where it exerts its biological properties. In malaria; CRP is 
believed to prevent entry of the sporozoite into the hepatocyte(Bachou et 
al., 2006). 
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 Clinically, CRP can be measured with several standardized, 
validated, and inexpensive high-sensitivity assays (Imrie et al., 2007). 
More than 20 prospective, epidemiologic studies demonstrate that human 
CRP is an independent predictor of risk of myocardial infarction (MI), 
stroke, peripheral arterial disease, and sudden cardiac death, even in 
apparently healthy individuals. CRP is surprisingly specific for the 
prediction of vascular events (Torres and Ridker, 2003).   
 The rise in CRP in malaria has already been reported by some 
authors, CRP has also been used as a good positive predictive indicator 
for the diagnosis of malaria in febrile people returning from a tropical 
area and is a marker for malaria in epidemiological studies (Torres and 
Ridker, 2003).   
1.2.5.2 Tumor necrosis factor (TNF): 
Tumor necrosis factor alpha (TNF – alpha) is a potent cytokine 
with a myriad of innate immune anti-tumor properties. It is involved in 
systemic inflammation and it is a member of a group of cytokines that all 
stimulate the acute phase reaction (Imrie et al., 2007). 
TNF primary role is in the regulation of immune cells (Kwiatkw 
Ski, 2005). 
 
          It causes apoptotic cell death, cellular proliferation, differentia-
tion, inflammation, and viral replication. 
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Dysregulation and, in particular, overproduction of TNF have been 
implicated in a variety of human diseases other than  cancer (Rudin et al., 
1997).  
TNF-alpha has a critical role in the bone and cartilage damage 
associated with rheumatoid arthritis (RA). TNF-alpha may be involved in 
the pathogenesis and/or progression of gestational diabetes mellitus 
(GDM). TNF-alpha is expressed in the  myocardium during compensated 
pressure-overload hypertrophy and contributes to post ischemic 
myocardial dysfunction. The serum levels of TNF-alpha were also 
significantly elevated in active WG (Wagener's granulomatosis), in the 
stages of HIV associated disease, and in the spinal cord arthritic patients 
(Ubalee et al., 2001 ). 
TNF is synthesized by macrophages and activated T- helper cells 
which in turn is responsible for the characteristics of malaria fever and 
induction of acute phase proteins such as (CRP) (Ubalee et al., 2001 ). 
TNF synthesis in falciparum malaria is down regulated by IL2 
produced by Th 2 cells and the activation of memory Th 2 cell producing 
IL-10 may partly be the reason for diminished malaria symptoms 
exhibited by many patients living in endemic areas. Despite its central 
role in malaria pathology , the function of TNF in controlling parasite 
growth should be considered. Various studies using antibodies, 
recombinant cytokines  or knock-out  mice  have shown that  the 
secretion  of TNF is an important effecter of  cerebral malaria (Rudin et 
al., 1997). 
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TNF has been shown to inhibit a mouse malaria parasite in vivo, 
and Plasmodium falciparum in vitro TNF enhances neutrophil and 
macrophage phagocytosis killing the sexual blood stages. Fever produced 
as a result of TNF release may help to limit parasite growth (Kwiatkw 
Ski, 2005). 
1.2.5.3 Serum magnesium: 
Magnesium (Mg) is present in the plant pigment cholorophyll, 
making plant foods a source of this mineral. We absorb about 30% to 
40% of the magnesium in our diets, but absorption efficiency can 
increase to 80% when intakes of magnesium are low. Vitamin D, may 
enhance magnesium absorption (Rudin et al., 1997). 
The diagnostic implications of changes in serum magnesium levels 
have become evident in recent years. Serum magnesium levels, however, 
like serum calcium, normally are maintained within very narrow limits so 
that highly accurate and specific analytical methods are required to detect 
the relatively small changes which may occur in certain disease states 
(Naylor, 2003). 
       The key pathogenic event in acute falciparum malaria infection is the 
hemolysis of both infected and uninfected red blood cells. Therefore, the 
increased serum magnesium concentration might occur because of the 
hemolysis since red blood cells contain high amounts of magnesium. 
Thus, the increased serum magnesium has potential application as a 
biomarker of acute falciparum malaria infection in adults (Imrie et al., 
2007). 
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CHAPTER TWO 
MATERIAL AND METHODS 
 
2.1 Material: 
2.1.1 Study population: 
A total of thirty two school children whose ages ranged between 
five to sixteen years old were chosen at random from Senar area. Sixteen 
of these children were with a medical history of malaria. The remaining 
sixteen were apparently healthy, and they were selected to serve as a 
control group. 
Consent of children involved was taken from their teachers and 
parents. 
2.1.2 Samples 
Three ml of blood sample were collected from each subject by 
venipuncture. Blood samples were collected in the morning (8-10 a.m.). 
Samples were allowed to clot and serum was immediately separated by 
centrifugation for 10 min. Serum was then stored at 4ºC and then 
analyzed. 
2.1.3 Equipment 
1. Photometer: Bio systems BTS – 310 Photometer. 
2. Pipettes: 
• Manual pipette was used for pipetting samples and standards at 
the beginning of the assay. 
• Automatic pipettes delivering 200µl 500µl and 1 ml were used 
for subsequent reagent additions. 
 29
3. Vortex mixer: GENIE 2. 
4. Test tubes with round bottomed 12 × 75 mm glass. 
5. Magnetic racks and separators compatible with 12 × 75 mm test-
tubes. 
6. 37ºC water bath. 
7. Refrigerator. 
8. Timer 
9. Various glassware including measuring cylinder beakers and 
reagent bottles of varying capacities. 
2.1.4 Reagents: 
2.1.4.1 Reagents for serum tumor necrosis factor (TNF) estimation: 
• TNF-alpha standards 
• Biotinylated TNF-alpha antibody 
• Streptavidin-peroxidase conjugate (SPconjugate) 
• Mixed diluent concentrate 
• Wash buffer concentrate 
• Chromogen substrate 
• Stop solution. 
2.1.4.2 Reagents for serum c-reactive protein (CRP) estimation: 
• C-reactive protein antibody 
• Immage immunochemistry systems wash solution 
• Buffer 
• Diluent 
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2.1.4.3 Reagents for serum magnesium estimation: 
• Methylthymol blue (MTB) 
• Barium salt of (oxyethylenenitrilo) 
• Tetra acetic acid 
• (Ba.EGTA), 
• Buffer. 
2.2 Methods 
Estimation of (TNF) is carried out by enzyme linked immuno-
sorbent assay (Elisa) described by (Ho, et al.,1986) Quantitative 
determination of human C-reactive protein in serum is done by rate 
nephelomertry and serum magnesium is measured by a modification of 
Methylthymol blue complexometric methods. 
2.2.1 Tumour necrosis factor (TNF) estimation: 
The enzyme linked immunosorbent assay (Elisa technique) is used 
for the measurement of (TNF) in human serum. The time required to 
complete an assay is approximately 5 hours. 
Principle: 
A murine monoclonal antibody specific for human TNF-alpha has 
been recoated onto a microplate. TNF-alpha in standards and samples is 
sandwiched by the immobilized antibody and biotinylated polyclonal 
antibody specific for human TNF. 
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Assay procedure: 
• All reagents, working standards and samples were prepared.  All 
reagents were then brought to room temperature before use. The 
assay was performed at room temperature (20-30ºC). 
• Excess microplate strips were removed from the plate frame and 
returned immediately to the foil pouch with desiccant inside.  The 
pouch was resealed securely to minimize exposure to water vapour 
and stored in vacuum desiccators. 
• 50 µl of standard or sample were added to each well and then  
microplates were  covered and incubated for two hours. The timer 
was started after the last sample addition. 
• Washing was done five times with 200 µl of Wash Buffer. The 
plate were inverted to decant the contents, and hit 4-5 times on 
absorbent paper towel to remove liquid at each step. 
• 50 µl of Biotinylated TNF-alpha antibody were added to each well 
and incubated for two hours. 
• Washing was done five times with 200 µl of wash buffer as above. 
• 50 µl of chromogen substrate were added to each well  and 
incubated for approximately 15 minutes or till the optimal blue 
color density developed. The plate was taped gently  to ensure 
through mixing and the bubbles in the well were broken with a  
pipette tip. 
• 50 µl of stop solution were added to each well . The color was 
changed from blue to yellow. 
• The absorbance was read at a wavelength of 450 nm immediately. 
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2.2.2 C-reactive protein (CRP) estimation: 
Principle: 
CRP  levels was measured by nephelomerty method described by 
Bland and Altman (1986) . 
Procedure: 
 After setup, reagents, coded calibrators, controls and samples 
were loaded  onto the system and then analyzed. 
2.2.3 Serum magnesium estimation: 
Principle: 
Methylthymol blue MTB forms a blue complex with magnesium. 
Calcium interference is minimized by forming a complex between 
calcium and Ba-EGTA (chelating agent). The amount of MG-MTB 
complex formed is proportional to the magnesium concentration and is 
measured using a dichromatic (600 and 510 nm) endpoint technique 
described by Mann and Yoe 1956 . 
Procedure: 
This was performed on the dimension clinical chemistry system 
after it  had been calibrated. 
Test steps: 
Sampling, reagent delivery, mixing, processing, and printing of 
results were automatically performed by the dimension system, based on 
the procedure of spectrophotometery .  
2.2.4 Statistical analysis: 
These were carried out using samples -t test, Standarad error and 
correlations. 
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CHAPTER THREE 
RESULTS 
3.1 Serum biomarkers: 
3.1.1 Serum c-reactive protein (CRP) levels:  
 The levels of C-reactive protein (CRP) in Malaria patients and 
control group, expressed as means ± standard error (S.E) are shown in 
table (1), and presented in figure (5). CRP levels of malaria patients at 
3.55 ± 1.52 are found to be significantly higher (P < 0.003).  compared to 
the control group. Referance value of serum CRP is 1– 1.5 mg/dl . 
 
Table (1): C-reactive protein (CRP) in malaria patients and the control 
group. 
CRP (mg/dl) (mean  ± 
SE) Group 
3.55 ± 1.52 Control (n=16) 
1.55  ±  0.58 Patients (n=16) 
 
n= number of specimens. 
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Figure (5): The C-reactive protein profiles in malaria patients and the 
control group. 
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3.1.2 Serum magnesium levels: 
 The serum levels of magnesium in the patients and the control 
group were shown in table (2) and profiles illustrated in figure (6). The 
mean value of serum magnesium in patients was compared with mean 
value of the control group, which was found to be significantly lower ( P 
value < 0.004)  . Referance value of serum magnesium is (1.8 – 3 mg/dl )  
 
Table (2): Serum magnesium in malaria patients and the control group. 
 
Serum (mg/dl) 
(mean  ± SE) Group 
1.11  ±  0.68 Control (n=16) 
1.85  ±  0.79 Patients (n=16) 
 
n= number of specimens 
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Figure (6): Serum magnesium profiles (mg/dl) in malaria patients and the 
control Group: 
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3.1.3 Tumor necrosis factor (TNF – alpha) levels:  
 Table (3) shows the serum levels of tumor necrosis factor – 
alpha, which is illustrated in figure (7) . The mean levels of TNF – alpha 
in patients are higher than the upper normal range.(referance value of 
serum TNF – alpha is 1– 2 ng/dl). However , the control group level is 
within the normal reference value. TNF mean levels in patients and  the 
control group indicated that the TNF is signficantly higher among infectd 
children (P < 0.002). 
 
Table (3): Tumor necrosis factor (TNF – alpha) levels in malaria patients 
and the  control group. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TNF level (ng/dl) 
(mean  ± SE) Group 
2.69 ±  0.74 Control(n=16) 
1.50  ±  0.18 Patients(n=16) 
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Figure (7): TNF profiles in malaria patients and the control Group in 
(ng/dl): 
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3.1.4 Hemoglobin levels: 
 Levels of hemoglobin in patients and the control group are 
shown in table (4) and in figure (8). The levels of hemoglobin in patients 
were found to be significantly ( P value < 0.001)  lower than the  control 
group , (referance value of hemoglobin is 12 – 14 g/dl in females , 14- 16 
g/dl in males). 
 
Table (4): Hemoglobin levels in malaria patients and the control group. 
 
hemoglobin  (g/dl) 
(mean  ± SE) Group 
10.9  ±  1.22 Control (n=16) 
13.0  ±  2.21 Patients (n=16) 
 
 
n= number of specimens 
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Figure (8): Hemoglobin profiles in patients and the control group in  
(g/dl) 
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3.2 Correlations between biomarkers and other factors among  the 
patients group: 
 3.2.1: Correlation between serum magnesium and hemoglobin (Hb): 
 Table (5) shows the relation between serum magnesium and 
hemoglobin levels in the patients group illustrated in figure (9). Serum 
magnesium was found to be low and the hemoglobin levels were low in 
malaria patients , There was a negative  correlation between the two 
groups  . 
 
Table (5): Correlations between serum magnesium (mg/dl) and 
hemoglobin levels in (g/dl)  among patients. 
 
(mean  ± SE) correlation Parameter 
1.11  ±  0.68 
10.9  ±  1.22 0.06 
Serum magnesium  
Hb 
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Figure (9): Correlation, between Serum magnesium and hemoglobin (Hb) 
in malaria patients. 
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CHAPTER FOUR 
 
DISCUSSION 
 
4.1   Serum inflammatory biomarkers during malaria infections: 
4.1.1 Serum C-reactive protein: 
Human C-reactive protein (CRP) is clinically important in  
classical acute phase response (APR) (Imrie et al., 2007).   
Many analysis showed that CRP levels were significantly 
associated with splenomegaly, fever, hemoglobin, and age. CRP levels 
also increased with increasing parasitemia in  malaria infections (Imrie et 
al., 2007).The present study is in agreement with previous similar  
reports. This  inflammatory biomarker though definitively high in 
malaria infection can not be used as a diagnostic parameter. However , it 
may be of value in prognosis and other aspects of this biomarker such as 
timing of production , intensity of effects during various stages of the 
disease which  may prove to be  important in terms of treatment . 
4.1.2 Serum magnesium level: 
  Serum magnesium concentration was measured in another study 
(Anderson et al., 2000 )  in 4 adult patient (age range: 18–40 yr) 
presenting with uncomplicated falciparum malaria infection and a control 
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group. Magnesium concentration in the patients was 1950.0 ±  10.0 
µ g/dl. The control serum magnesium was 640.0 ±  40.0 µ g /dl. This 
represents an over threefold increase in serum magnesium levels above 
normal value (P<0.01). The key pathogenic event of acute falciparum 
malaria infection is the hemolysis of both infected and uninfected red 
blood cells. Therefore, the increase of  serum magnesium concentration 
might occur because of the hemolysis as red blood cells contain high 
amounts of magnesium. The increased serum magnesium has potential 
application as a biomarker of acute falciparum malaria infection in adults 
(Anderson, et al., 2000 ).  
The present study showed that the serum Mg levels in  malarial 
patients was lower  compared with their counterparts  the  control group 
which was below normal reference value , this raises some questions 
pertaining to whether Sudanese at large have different reference range. 
reference value have been recently questioned regarding  ranges. A 
suitable example for this point , there is an ongoing debate on narrowing 
the TSH reference range in adults ,within the range of normal for thyroid 
hormone concentration, there is a rather wide degree of variation from 
individual to individual (Arem,2000 ) . 
The following reference ranges represent commonly used thyroid 
function reference ranges. However, ranges and units of measurement 
may vary from one laboratory to another. Patient results must be 
compared to the reference range of the appropriate testing facility (Arem, 
2000 ) . 
Adult Reference Ranges: 
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T4 = 5.6-13.7 ug/dl (mcg/dl) 
FT4 = 0.8-1.5 ng/dl 
T3= 87-180 ng/dl 
FT3 = 230-420 pg/d; 
TSH = 0.4-4.5 mIU/L (mU/L) 
4.1.3 Serum tumour necrosis factor: 
Tumour necrosis factor alpha (TNFα) is thought to play a role in 
the development of immunity in malaria infectious. 
Some malaria disease severity is attributed to the induction of the pro-
inflammatory cytokines TNF-alpha (Sinha et al., 2008) . 
 
Susceptibility/resistance to plasmodium falciparum malaria has been 
correlated with polymorphisms in more than 30 human genes with most 
association analyses having been carried out on patients from Africa and 
Southeast Asia. Significantly higher TNF levels were observed in 
patients with severe malaria (Sinha et al., 2008). 
 
  Plasma concentration of TNF-alpha and IFN-gamma were higher 
in parasitaemic than aparasitaemic individuals and donors who had 
clinical malaria had higher levels of TNF-alpha.There was appositive 
correlation between age of the individual and the concentration of plasma 
TNF-alpha and IFN-gamma suggesting that the production of these 
cytokines could be modulated by repeated malarial infections (Carter et 
al., 2005). 
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The findings in the present study is in agreement with the findings of 
other workers, where peripheral levels of TNF, and ferritin were found to 
be elevated during Placental malaria. (Kabyemela et al., 2008). 
 
High level of serum TNFα correlates with resistance to malaria 
infection which agrees with the findings of the present study that TNFα 
level was significantly elevated in  the infected children compared to 
their counterpart control group, Whether this is an indication of different 
mechanisms of pathogenesis or reflects differences in immunological 
responses at different stages of  human life remains to be investigated.  
4.1.4 Hemoglobin levels:  
Anemia or low hemoglobin commonly occurs in chronic infection, 
inflammation and malignancy. In the present study hemoglobin levels in 
malaria patients were significantly low (10.9  ±  1.22 ) and some of them 
were suffering from anemia compared to their counterpart control group. 
When these children encounter the malaria their hemoglobin was 
decreased but not to extent of affecting serum  magnesium levels. In  this  
situation one is question about the sensitivity and specificity of 
quantifying method used for estimation, or perhaps if the mineral 
chelated during the process. 
  This study showed that there is no direct correlation between 
hemoglobin and serum magnesium levels among malaria patients which 
may be attributed to  other factors  affecting the magnesium  levels in 
these children .  
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CHATER FIVE 
CONCLUSION AND RECOMMENDATION 
 
5.1 Conclusion  
It's concluded from the present investigations that the malaria can 
affect some inflammatory biomarkers such as c-reactive protein 
concentrations which were  increased in malaria patient and of high 
incidence among children. In accordance with other studies there is a 
clear difference in serum magnesium concentration in the two groups                         
(patients and control) that the malaria patients had levels below  the 
normal range. TNF level is increased among patients, hemoglobin was 
low among these children, also there is no clear relationship between 
these factors such as age, and hemoglobin and c-reactive protein and 
serum magnesium respectively. 
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5.2 Recommendations 
* More investigations are needed to resolve the complexity of 
the issue. 
* Attention should be given to the malaria problems in the 
country in a coordinated manner. 
* Socioeconomic, environmental and genetical factors as 
underlying causes of inflammatory biomarker imbalance 
during malaria infections. Which should be addressed and 
investigated through maltidisciplinary teams. 
* Parallel study need to be done in adults (divided into males 
and females). 
* Cohort studies should be encouraged and facilitated though 
governmental bodies and the private sector, which will 
benefit future work and planning regarding infectious 
disease and inflammatory biomarkers. 
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